Columnist Caroline Gainer had been searching for ways to improve her rest. Now, with help of her Fitbit, she's found her ...

Trelegy Ellipta is a once-daily, single inhaler triple therapy from GSK, in collaboration with Innoviva, approved as a long-term maintenance treatment for certain patients with chronic obstructive ...

Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory disease of the lungs, in which the airways become blocked, causing cough with mucus, wheezing, and shortness of breath. Symptoms ...

COPD is among the leading causes of death in industrialized countries, and new pharmacological treatments are being developed to help patients with this disease. But a spectrum of non-pharmacological ...

Prednisolone is a prescription medicine, a steroid, used to treat various conditions including breathing disorders. Steroids are a group of hormones with similar chemical structures that help to ...

GSP 304 (tiotropium bromide) is a mist that Glenmark Pharmaceuticals is developing to widen the narrowed airways that are a hallmark of chronic obstructive pulmonary disease. Glenmark is working on ...

Although there is no cure for COPD yet, there are several approved treatments that can help manage the disease and ease symptoms. Learn more about some of the specific therapies used to treat this ...

Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory lung disease mainly caused by long-term exposure to certain irritants, including cigarette smoke, chemical fumes, dust, and air ...

A new double-combination therapy that promotes lung expansion and airway clearance has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of people with lung diseases ...

Theophylline is a bronchodilator that’s been used in the treatment of COPD for more than seven decades. It is used to treat wheezing or shortness of breath caused by asthma, bronchitis, emphysema and ...

DirectRx, a specialty pharmacy for people with chronic health disorders, is now part of the exclusive U.S. pharmacy network distributing Ohtuvayre (ensifentrine), a newly approved therapy for chronic ...

Hoping to increase awareness of an often-debilitating and misdiagnosed lung condition called nontuberculous mycobacterial (NTM) lung disease, the COPD Foundation is hosting a Facebook discussion on ...